Stevanato Group S.p.A. STVN
Analyst Ratings
- Consensus
- Moderate Buy — 4 Buy · 2 Hold · 0 Sell (6 analysts)
- Avg. Price Target
- $24.33 (+26.0% upside)
Key Stats
- Today's Range
- $19.01 – $19.54
- 50-Day Range
- $18.82 – $23.25
- 52-Week Range
- $12.89 – $28.00
- Volume
- 361K shs
- Average Volume
- 311K shs
- Market Cap
- $5.27 billion
- P/E Ratio
- —
- Dividend Yield
- 0.28%
Dividend
- Dividend Yield
- 0.28%
- Annual Dividend
- $0.05
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-06-11
Short Interest
- Short Interest
- 0.26%
- Days to Cover
- 1.00
About Stevanato Group S.p.A.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.
Related Stocks
Compare head-to-head: STVN vs NVDA·STVN vs AAPL·STVN vs GOOGL·STVN vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.